Literature DB >> 24418799

Exploring the decision to participate in the National Health Service Bowel Cancer Screening Programme.

Merryn Ekberg1, Matthew Callender, Holly Hamer, Stephen Rogers.   

Abstract

Cancer is a leading cause of mortality and one of the most feared diseases in modern society. A combination of early detection, accurate diagnosis and effective treatment provides the best defence against cancer morbidity; therefore, promoting cancer awareness and encouraging cancer screening is a priority in any comprehensive cancer control policy. Colorectal cancer is the third most common form of cancer in the UK and in an effort to reduce the high incidence, prevalence, morbidity and mortality rates, the National Health Service (NHS) has introduced the NHS Bowel Cancer Screening Programme (NHS BCSP). For the NHS BCSP to succeed in its goal of reducing the incidence and prevalence rates for colorectal cancer, individuals need to be persuaded to complete the test. Since it was first introduced in 2007, however, participation rates have been low. In an effort to understand why participation rates remain low, this article reports on the findings of a series of focus groups conducted in the East Midlands of England. These focus groups were designed to explore the factors that influence an individual's decision to participate in cancer screening. The findings revealed eight factors that affected participation in the NHS BCSP: (i) the association of screening with entry into old age; (ii) prior experience with health systems; (iii) the support of a significant other; (iv) individual perceptions of risk (and benefit); (v) fear of becoming a cancer patient after the screening test; (vi) lack of disease symptoms; (vii) embarrassment associated with completing the test and (viii) messages that adopt a paternalistic ethos. Overall, our results suggest that more people may participate in the screening programme if it was more sensitive to these psychosocial and contextual factors that shape an individual's decision to be tested.

Entities:  

Mesh:

Year:  2014        PMID: 24418799     DOI: 10.1097/CEJ.0000000000000007

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  6 in total

Review 1.  Uncovering the barriers to undergoing screening among first degree relatives of colorectal cancer patients: a review of qualitative literature.

Authors:  Ker-Kan Tan; Violeta Lopez; Mee-Lian Wong; Gerald Choon-Huat Koh
Journal:  J Gastrointest Oncol       Date:  2018-06

2.  Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301).

Authors:  Aminah Jatoi; Hyman Muss; Jake B Allred; Harvey J Cohen; Karla Ballman; Judith O Hopkins; Ajeet Gajra; Jacqueline Lafky; Antonio Wolff; Lisa Kottschade; Julie Gralow; Arti Hurria
Journal:  Psychooncology       Date:  2015-05-20       Impact factor: 3.894

3.  Sinomenine, a COX-2 inhibitor, induces cell cycle arrest and inhibits growth of human colon carcinoma cells in vitro and in vivo.

Authors:  Haibo Yang; Peihao Yin; Zhan Shi; Yanchun Ma; Chenggen Zhao; Jampu Zheng; Teng Chen
Journal:  Oncol Lett       Date:  2015-10-29       Impact factor: 2.967

4.  Characteristics and attitudes of first round invitees in the Irish National Colorectal Cancer Screening Programme.

Authors:  Susanne M O'Reilly; Katie N Hughes; Therese Mooney; Patricia Fitzpatrick; Diarmuid O'Donoghue; Sara McNally; Mary Codd; Elizabeth Ryan; Glen Doherty; Olivia Mason; Hugh E Mulcahy; Garret Cullen
Journal:  Frontline Gastroenterol       Date:  2020-06-10

5.  Socioeconomic inequalities in attitudes towards cancer: an international cancer benchmarking partnership study.

Authors:  Samantha L Quaife; Kelly Winstanley; Katie A Robb; Alice E Simon; Amanda J Ramirez; Lindsay J L Forbes; Kate E Brain; Anna Gavin; Jane Wardle
Journal:  Eur J Cancer Prev       Date:  2015-05       Impact factor: 2.497

6.  Piloting the Impact of Three Interventions on Guaiac Faecal Occult Blood Test Uptake within the NHS Bowel Cancer Screening Programme.

Authors:  Becky White; Emily Power; Monika Ciurej; Siu Hing Lo; Katherine Nash; Nick Ormiston-Smith
Journal:  Biomed Res Int       Date:  2015-10-07       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.